"Fluoxetine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
Concept/Terms
Fluoxetine- Fluoxetine
- N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
- Fluoxetin
Below are MeSH descriptors whose meaning is more general than "Fluoxetine".
Below are MeSH descriptors whose meaning is more specific than "Fluoxetine".
This graph shows the total number of publications written about "Fluoxetine" by people in Harvard Catalyst Profiles by year, and whether "Fluoxetine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 8 | 4 | 12 |
| 1993 | 6 | 9 | 15 |
| 1994 | 9 | 6 | 15 |
| 1995 | 9 | 2 | 11 |
| 1996 | 12 | 7 | 19 |
| 1997 | 9 | 10 | 19 |
| 1998 | 13 | 4 | 17 |
| 1999 | 10 | 2 | 12 |
| 2000 | 8 | 2 | 10 |
| 2001 | 6 | 5 | 11 |
| 2002 | 16 | 5 | 21 |
| 2003 | 10 | 3 | 13 |
| 2004 | 21 | 6 | 27 |
| 2005 | 11 | 4 | 15 |
| 2006 | 12 | 4 | 16 |
| 2007 | 11 | 6 | 17 |
| 2008 | 8 | 6 | 14 |
| 2009 | 10 | 4 | 14 |
| 2010 | 10 | 9 | 19 |
| 2011 | 2 | 3 | 5 |
| 2012 | 9 | 2 | 11 |
| 2013 | 3 | 3 | 6 |
| 2014 | 3 | 1 | 4 |
| 2015 | 7 | 4 | 11 |
| 2016 | 5 | 9 | 14 |
| 2017 | 3 | 0 | 3 |
| 2018 | 5 | 1 | 6 |
| 2019 | 5 | 0 | 5 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 1 | 1 |
Below are the most recent publications written about "Fluoxetine" by people in Profiles.
-
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors. JAMA Netw Open. 2022 02 01; 5(2):e220194.
-
Efficacy of Fluoxetine for Post-Ischemic Stroke Depression in Tanzania. J Stroke Cerebrovasc Dis. 2022 Jan; 31(1):106181.
-
Chasing the Offending Medication: When Antidepressants Lead to Hypoglycemia. J Clin Psychopharmacol. 2021 Nov-Dec 01; 41(6):698-699.
-
A Sequential Multiple Assignment Randomized Trial (SMART) study of medication and CBT sequencing in the treatment of pediatric anxiety disorders. BMC Psychiatry. 2021 06 30; 21(1):323.
-
Moderators and Predictors of Response After 36 Weeks of Treatment in the Treatment for Adolescents with Depression Study (TADS). Res Child Adolesc Psychopathol. 2021 11; 49(11):1489-1501.
-
Repeated fluoxetine treatment induces transient and long-term astrocytic plasticity in the medial prefrontal cortex of normal adult rats. Prog Neuropsychopharmacol Biol Psychiatry. 2021 04 20; 107:110252.
-
Stress-mediated hyperactivity and anhedonia resistant to diazepam and fluoxetine in drosophila. Stress. 2021 01; 24(1):96-106.
-
A placebo prognostic index (PI) as a moderator of outcomes in the treatment of adolescent depression: Could it inform risk-stratification in treatment with cognitive-behavioral therapy, fluoxetine, or their combination? Psychother Res. 2021 01; 31(1):5-18.
-
Changes in Gut Microbiota by Chronic Stress Impair the Efficacy of Fluoxetine. Cell Rep. 2020 03 17; 30(11):3682-3690.e6.
-
Implementation research for public sector mental health care scale-up (SMART-DAPPER): a sequential multiple, assignment randomized trial (SMART) of non-specialist-delivered psychotherapy and/or medication for major depressive disorder and posttraumatic stress disorder (DAPPER) integrated with outpatient care clinics at a county hospital in Kenya. BMC Psychiatry. 2019 12 28; 19(1):424.